Peptide Therapeutics Market is growing at a CAGR of 8.7% from 2013 to 2019. By Transparency Market Research.

Peptide Therapeutics Market was valued at USD 14.1 billion in 2013 and is estimated to reach a market worth USD 25.4 billion in 2019 at a CAGR of 8.7% from 2013 to 2019.

Browse the full report at http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

The growth of the market is driven by factors such as rising incidences of cardiovascular diseases, metabolic diseases and technological enhancement in peptide synthesis. The Asian region offers future growth prospects to the peptide industry owing to vast unmet medical needs and rising disposable income of patients.

Amongst the application market, the cancer peptide segment accounted for the largest share of approximately 21% and is expected to grow at a healthy CAGR during the forecast period. The neuropeptides application segment is anticipated to grow at a CAGR of 9.4% from 2012 to 2018 due to the rise in number of neurological disorders such as Alzheimer's and Parkinson's disease.

The parenteral route of administration of peptides accounted for the largest share of around 86% in year 2011, in terms of routes of administration; however other routes of administration like oral, pulmonary, nasal and intradermal are also being tested and are estimated to experience healthy growth rate during the forecast period.

Technological enhancement with introduction of hybrid technology along with solid phase peptide syntheses (SPPS) is expected to enhance the growth of peptide therapeutics. The hybrid technology segment which provides the best of both solid and liquid syntheses is now being adopted by major players and hence this market is expected to see the highest growth of 12.1% from 2012 to 2018.

The North American peptide therapeutics market held majority of the market share of approximately 40% in 2011 owing to its developed economy. However, due to rise in cost containment and budgetary cuts in North America, emerging countries such as India, China and other Latin American countries is expected to see a healthy growth in the study period.

Some of the key market players are Eli Lilly, Roche, Amylin, Novo-Nordisk, Ipsen and others. The contract manufacturing organization (CMO) industry includes major players such as Bachem, Polypeptide Group, Lonza, Peptisyntha and others.

Peptide Therapeutics Market, by Applications

Cancer

Metabolic

Cardiovascular

Dermatology

Anti-Infection

Neurology

Gastro Intestinal

Renal

Respiratory

Pain

Others

Peptide Therapeutics Market, by Route of Administration

Parenteral

Oral

Pulmonary

Mucosal

Others

Peptide Therapeutics Market, by Types

Innovative

Generics

Peptide Therapeutics Market, by API Peptide

In-House

CMO (Contract Manufacturing Organization)

Peptide Therapeutics by technology

Liquid Phase Peptide Synthesis (LPPS)

Solid Phase Peptide Synthesis (SPPS)

Hybrid

Peptide Therapeutics Market, by Geography

North America

Europe

Asia

RoW

For Sample Report Visit On:

http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=418

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.